CompletedNot Applicable

Novel Use of Extrapleural Autologous Blood Injection in CT-guided Percutaneous Lung Biopsy

Turkey (Türkiye)139 participantsStarted 2018-10-01

Plain-language summary

The purpose of this study is to evaluate the rate of iatrogenic pneumothorax and the need for intervention with extrapleural autologous blood injection (EPABI) along with intraparenchymal autologous blood patch injection (IABPI) or IABPI-alone in CT-guided percutaneous lung biopsy.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥18 years of age * Referred for CT guided biopsy of lung lesion * Target lesion of any size * Target lesion located any away from visceral pleura based on the needle path * Needle path without transgression of a pleural fissure, bleb, or bulla is possible * Coaxial biopsy technique using Bard 19-Gauge introducer needle * Needle length =16 Exclusion Criteria: * Passage through non-aerated lung or tissue * More than 1 biopsy on the same side requiring more than 1 pleural puncture * History of prior ipsilateral lung interventions including: Chest tube placement Surgery Pleurodesis Radiation treatment

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

To evaluate the rate of iatrogenic pneumothorax and the need for intervention with extrapleural autologous blood injection (EPABI)

Timeframe: 1 years

Trial details

NCT IDNCT04415255

SponsorNamik Kemal University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-04-30

View on ClinicalTrials.gov More Lung Biopsy trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.